Martin Hilgarth
- Co-authors
- Medhat ShehataRainer HubmannJosef D. SchwarzmeierMarkus DuechlerRudolf BergerDita DemirtasSusanne SchnablMarkus Dettke
- Topics
- Chronic Lymphocytic Leukemia Research (19 papers)Lymphoma Diagnosis and Treatment (7 papers)Glycosylation and Glycoproteins Research (5 papers)
- Partner nations
- AustriaSlovakiaUnited States
In The Last Decade
Martin Hilgarth
26 papers receiving 642 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 338
- Genetics 267
- Pathology and Forensic Medicine 168
- Immunology 141
- Oncology 113
Countries citing papers authored by Martin Hilgarth
This map shows the geographic impact of Martin Hilgarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Hilgarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Hilgarth more than expected).
Fields of papers citing papers by Martin Hilgarth
This network shows the impact of papers produced by Martin Hilgarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Hilgarth. The network helps show where Martin Hilgarth may publish in the future.
Co-authorship network of co-authors of Martin Hilgarth
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Hilgarth. A scholar is included among the top collaborators of Martin Hilgarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Hilgarth. Martin Hilgarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 11 | |
| 3 | 7 | |
| 4 | 25 | |
| 5 | 31 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 91 | |
| 9 | 1 | |
| 10 | 24 | |
| 11 | 2 | |
| 12 | 51 | |
| 13 | 1 | |
| 14 | 59 | |
| 15 | 63 | |
| 16 | 111 | |
| 17 | 19 | |
| 18 | Predictive value of clone-specific CDR3 PCR in high-grade non-Hodgkin's lymphoma: long-term persistence of a clone-specific rearrangement in a patient with secondary high-grade NHL in remission after high-dose therapy. | 2 |
| 19 | 73 | |
| 20 | 2 |
About Martin Hilgarth
Martin Hilgarth is a scholar working on Genetics, Immunology and Allergy and Complementary and Manual Therapy, having authored 27 papers that have together received 653 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (7 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Genetics (267 citations), Complementary and Manual Therapy (26 citations) and Hematology (108 citations). Martin Hilgarth has collaborated with scholars based in Austria, Slovakia and United States. Frequent co-authors include Medhat Shehata, Rainer Hubmann, Josef D. Schwarzmeier, Markus Duechler, Rudolf Berger, Dita Demirtas, Susanne Schnabl, Markus Dettke, Andrea Hoelbl‐Kovacic and Christoph Zielinski. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.